Fri, 15 Apr 2011 | DIVISION SALE
UK drugs giant GlaxoSmithKline is preparing to divest 19 brands as it focuses in on its rapid growth products.
The brands facing the chop are mainly sold in Europe and America, and together generated revenues of about £500 million last year, representing ten per cent of the group’s consumer healthcare sales.
Glaxo plans to sell the non-core assets by the end of 2011, and is to commence discussions with interested parties in the next month or so.
Products to be divested include Nytol, a sleep aid; Alli, the controversial weight management drug; Debrox, an earwax cleanser; Valda, a cough/cold treatment; and Abtei, a vitamin supplements.
Glaxo’s CEO Andrew Witty said, “It is important that we focus this business around product categories, brands and markets where we have the most depth and competitive advantage, with the best prospects for strong growth.”
Key brands that are to be retained include Sensodyne, Horlicks and Panadol. The three growing categories are oral health, nutrition, and wellness and over the counter products.
Glaxo say that having refocused on its core products it will hold market-leading positions in smoking control, dental sensitivity, denture care, analgesics and nutrition.
This vibrant and rapidly growing online business specialises in British craft beer gift hampers, tapping into both D2C and B2B marketplaces, making it an ideal investment for those looking to capitalise on the thriving gift industry. With a streamlin...
This niche business offers a rare opportunity to acquire a leading specialist in front garden design, restoration, and creation for period properties across South East England, with a strong reputation for high-quality finishes and heritage-sensitive...
Explore an opportunity to acquire a thriving multi-channel e-commerce brand with a considerable track record of success, specialising in fashion and gadgets.
22
|
Aug
|
Animalcare acquires new research programme for horses and dogs | BUSINESS SALE
York-based Animalcare Group plc has expanded its pipeline of...
22
|
Aug
|
Coastal Dorset development site with planning permission comes to market | COMMERCIAL PROPERTY
A prime coastal development opportunity has been launched to...
22
|
Aug
|
UK Government takes control of Speciality Steel after insolvency | ADMINISTRATION
Speciality Steel UK (SSUK) has been taken over by the UK gov...
22
|
Aug
|
UK Government takes control of Speciality Steel after insolvency | ADMINISTRATION
Speciality Steel UK (SSUK) has been taken over by the UK gov...
22
|
Aug
|
Coastal Dorset development site with planning permission comes to market | COMMERCIAL PROPERTY
A prime coastal development opportunity has been launched to...
22
|
Aug
|
Animalcare acquires new research programme for horses and dogs | BUSINESS SALE
York-based Animalcare Group plc has expanded its pipeline of...
Business Sale Report is the complete resource for finding genuine acquisition opportunities.
Join today to receive:
All this and much more, including the latest M&A news and exclusive resources
Please choose your settings for this site below. For more information please read our Cookie Policy
These cookies are necessary for our website to function properly and provide you with access to all features.
These are analytics cookies that help us to improve the way our website works.
These are used to improve the functional performance of the website and make it easier for you to use.